This global role focuses on the medical evidence strategy for adult RSV vaccines, including effectiveness and burden studies, with a worldwide focus and support for Asia.
Base: $230,900.00 - $384,800.00; Bonus/Equity: 25.0% bonus target, eligible for share-based long term incentive; Benefits: Comprehensive and generous benefits package including 401(k), paid time off, medical, dental, and vision coverage
Must-have
Nice-to-have
Permanent work authorization required